Quinoxalines useful as inhibitors of protein kinases
US7592340B2 · kind B2 · utility
23Cited by
1References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 3, 2004 |
| Grant date | Sep 22, 2009 |
| Priority date | — |
| Expiry date | May 31, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of formula I useful as inhibitors of protein kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.